Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients

Journal of Clinical Psychopharmacology

Volumn 4, Issue 4, 1984, Pages 194-198

  Shvartsburd, Alla ^a   Sajadi, Cyrus ^a   Morton, Vona ^a   Mirabi, Moshen ^a   Gordon, Jack ^a   Smith, Robert C ^a,b  

^a Texas Research Institute of Mental Sciences ^*  (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; MESORIDAZINE; THIORIDAZINE;

CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; DRUG THERAPY; HUMAN; SCHIZOPHRENIA; THERAPY;

ERYTHROCYTES; HALOPERIDOL; HUMANS; OUTPATIENTS; PATIENT COMPLIANCE; SCHIZOPHRENIA; THIORIDAZINE; TIME FACTORS;

EID: 0021214269     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/00004714-198408000-00004     Document Type: Article

References (10)

1. Casper R, Garver DL, Dekirmenjian H, Chang S, Davis JM. Phenothiazine levels in plasma and red blood cells. Arch Gen Psychiatry 1980;37:301–5.
2. Smith RC, Vroulis G, Shvartsburd A, et al. RBC and plasma levels of haloperidol and clinical response in schizophrenia. Am J Psy-chiatry 1982;139:1054–6.
3. Smith RC, Baumgartner R, Misra CH et al., Haloperidol: plasma levels and prolactin response as predictors of clinical improvement in schizophrenia. Chemical vs. radioreceptor plasma level assays. Arch Gen Psychiatry (in press).
4. Dysken MW, Javaid JI, Chang S, Schaffer C, Shabid A, Davis JM. Fluphenazine pharmacokinetics and clinical response. Psychopharmacology 1981;73:205–10.
5. WodeHelgodt B, Borg S, Fyro B, Sedvall G. Clinical effects and drug concentration in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine. Acta Psychiatr Scand 1978;58:149–73.
6. May PR, Van Putten T, Jenden DJ, Yale C, Dixon WJ. Chlorpromazine levels and the outcome of treatment on schizophrenic patients. Arch Gen Psychiatry 1981;58:202–7.
7. Shvartsburd A, Dekirmenjian H, Smith RC. Blood levels of haloperidol in schizophrenic patients. J Clin Psychopharmacol 1983;3:7–12.
8. Shvartsburd A, Nwokeafor V, Smith RC. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients. Psychopharmacology 1984;82:55–61.
9. Mavroidis ML, Kanter DR, Hirschowitz J, Garver DL. Clinical response and plasma haloperidol levels in schizophrenia. Psychopharmacology 1983;81:354–6.
10. Smith RC, Baumgartner R, Ravichandran GK, et al. Plasma and red cell levels of thioridazine and clinical response in schizophrenia. J Psychiatr Res (submitted for publication).